DARE vs DASH · rev $9.8K vs P/E 76, rev $13.72B
Dare Bioscience Inc (DARE) versus DoorDash, Inc. Class A Common Stock (DASH) — a side-by-side from cached financials, not a winner call.
Dare Bioscience Inc (DARE) is a biotechnology company listed on US.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Latest reported DARE revenue for 2024-12-31 was $9.8K. Net income was -$4.1M. Revenue was down 99.7% from 2023-12-31 to 2024-12-31. DARE currently screens at market cap $21.2M.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
DARE currently screens at market cap $21.2M. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Not investment advice. Open the DARE and DASH stock pages for the full models.
Not investment advice.